Menopause, obesity and inflammation: Interactive risk factors for Alzheimer's disease

Frontiers in Aging Neuroscience

Volumn 7, Issue JUN, 2015, Pages

  Christensen, Amy ^a   Pike, Christian J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Adiposity; Aging; Alzheimer's disease; Estrogen; Hormone therapy; Inflammation; Obesity

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E4; BETA SECRETASE 1; BRAIN DERIVED NEUROTROPHIC FACTOR; CLUSTERIN; ESTRADIOL; ESTROGEN; INSULIN; INTERLEUKIN 18; INTERLEUKIN 1BETA; LEPTIN; LEPTIN RECEPTOR; MESSENGER RNA; PLACEBO; PROGESTERONE; PROSTAGLANDIN E2; SOMATOMEDIN; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; AGE; AGING; ALZHEIMER DISEASE; ARTICLE; ASTROCYTOSIS; BLOOD BRAIN BARRIER; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC INFLAMMATION; COGNITIVE DEFECT; COMPLEMENT SYSTEM; CYTOKINE RELEASE; DEGENERATIVE DISEASE; DEMENTIA; DISEASE COURSE; DOWN REGULATION; ENERGY EXPENDITURE; ENVIRONMENTAL FACTOR; GENE MUTATION; GLIOSIS; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HELPER CELL; HEREDITY; HORMONAL THERAPY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOTHALAMUS; INFLAMMATION; INNATE IMMUNITY; INSULIN RESISTANCE; INSULIN RESPONSE; INTRAABDOMINAL FAT; LIPID DIET; LONG TERM POTENTIATION; MENOPAUSAL SYNDROME; MENOPAUSE; METABOLIC SYNDROME X; MICROGLIA; NERVE CELL PLASTICITY; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OSTEOPOROSIS; OVARIECTOMY; PATHOGENESIS; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RISK FACTOR; SPATIAL MEMORY; VASCULAR AMYLOIDOSIS; VASCULITIS; WAIST CIRCUMFERENCE; WEIGHT GAIN;

EID: 84936092088     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2015.00130     Document Type: Article

References (216)

1. F.M. LaFerla (2010) Pathways linking Abeta and tau pathologies. Biochem Soc Trans 38 993-5. doi: 10.1042/BST0380993
2. G.P. Morris, I.A. Clark, and B. Vissel (2014) Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease. Acta Neuropathol Commun 2 135. doi: 10.1186/s40478-014-0135-5
3. L. Mucke, and D.J. Selkoe (2012) Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction. Cold Spring Harb Perspect Med 2 a006338. doi: 10.1101/cshperspect.a006338
4. R.E. Tanzi (2012) The genetics of Alzheimer disease. Cold Spring Harb Perspect Med 2. doi: 10.1101/cshperspect.a006296
5. J.A. Hardy, and G.A. Higgins (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256 184-5.
6. J. Hardy (2006) Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal. J Alzheimers Dis 9 151-3.
7. K. Iqbal, F. Liu, C.X. Gong, and I. Grundke-Iqbal (2010) Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res 7 656-64.
8. H. Zempel, and E. Mandelkow (2014) Lost after translation: missorting of Tau protein and consequences for Alzheimer disease. Trends Neurosci 37 721-32. doi: 10.1016/j.tins.2014.08.004
9. G.S. Bloom (2014) Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 71 505-8. doi: 10.1001/jamaneurol.2013.5847
10. L. Mosconi, A. Pupi, and M.J. De Leon (2008) Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease. Ann N Y Acad Sci 1147 180-95. doi: 10.1196/annals.1427.007
11. J. Yao, J.R. Rettberg, L.P. Klosinski, E. Cadenas, and R.D. Brinton ( 2011) Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions. Mol Aspects Med 32 247-57. doi: 10.1016/j.mam.2011.10.005
12. B.V. Zlokovic (2011) Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 12 723-38. doi: 10.1038/nrn3114
13. R.E. Mrak, and W.S. Griffin (2005) Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging 26 349-54. doi: 10.1016/j.neurobiolaging.2004.05.010
14. S. Prokop, K.R. Miller, and F.L. Heppner (2013) Microglia actions in Alzheimer's disease. Acta Neuropathol 126 461-77.
15. C.L. Ogden, M.D. Carroll, B.K. Kit, and K.M. Flegal (2014) Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 311 806-14. doi: 10.1001/jama.2014.732
16. A.T. McGill (2014) Past and future corollaries of theories on causes of metabolic syndrome and obesity related co-morbidities part 2: a composite unifying theory review of human specific co-adaptations to brain energy consumption. Arch Public Health 72 31. doi: 10.1186/2049-3258-72-31
17. K. Rahmouni (2014) Obesity-associated hypertension: recent progress in deciphering the pathogenesis. Hypertension 64 215-21. doi: 10.1161/HYPERTENSIONAHA.114.00920
18. V.Z. Rocha, and P. Libby (2009) Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 6 399-409. doi: 10.1038/nrcardio.2009.55
19. A. Jayaraman, and C.J. Pike (2014) Alzheimer's disease and type 2 diabetes: multiple mechanisms contribute to interactions. Curr Diab Rep 14 476. doi: 10.1007/s11892-014-0476-2
20. B.M. Bettcher, and J.H. Kramer (2014) Longitudinal inflammation, cognitive decline, and Alzheimer's disease: a mini-review. Clin Pharmacol Ther 96 464-9. doi: 10.1038/clpt.2014.147
21. M. Michaud, L. Balardy, G. Moulis, C. Gaudin, C. Peyrot, B. Vellas, M. Cesari, and F. Nourhashemi (2013) Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc 14 877-82. doi: 10.1016/j.jamda.2013.05.009
22. T. Wyss-Coray, and J. Rogers (2012) Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med 2 a006346. doi: 10.1101/cshperspect.a006346
23. A. Altmann, L. Tian, V.W. Henderson, M.D. Greicius, and I. Alzheimer's Disease Neuroimaging Initiative (2014) Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol 75 563-73. doi: 10.1002/ana.24135
24. F. Bonomini, L.F. Rodella, and R. Rezzani (2015) Metabolic syndrome, aging and involvement of oxidative stress. Aging Dis 6 109-20. doi: 10.14336/AD.2014.0305
25. B. Kim, and E.L. Feldman (2015) Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome. Exp Mol Med 47 e149. doi: 10.1038/emm.2015.3
26. L.A. Profenno, A.P. Porsteinsson, and S.V. Faraone (2010) Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol Psychiatry 67 505-12. doi: 10.1016/j.biopsych.2009.02.013
27. K. Yaffe, T. Blackwell, A.M. Kanaya, N. Davidowitz, E. Barrett-Connor, and K. Krueger (2004) Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63 658-63.
28. L.B. Hassing, S.M. Hofer, S.E. Nilsson, S. Berg, N.L. Pedersen, G. McClearn, and B. Johansson (2004) Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing 33 355-61. doi: 10.1093/ageing/afh100
29. C.T. Cigolle, P.G. Lee, K.M. Langa, Y.Y. Lee, Z. Tian, and C.S. Blaum (2011) Geriatric conditions develop in middle-aged adults with diabetes. J Gen Intern Med 26 272-9. doi: 10.1007/s11606-010-1510-y
30. G.J. Biessels, F.E. De Leeuw, J. Lindeboom, F. Barkhof, and P. Scheltens (2006) Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus. J Neurol Neurosurg Psychiatry 77 304-7. doi: 10.1136/jnnp.2005.069583
31. J.A. Luchsinger, M.X. Tang, S. Shea, and R. Mayeux (2004) Hyperinsulinemia and risk of Alzheimer disease. Neurology 63 1187-92.
32. A.L. Fitzpatrick, L.H. Kuller, O.L. Lopez, P. Diehr, E.S. O'Meara, W.T. Longstreth, Jr., and J.A. Luchsinger (2009) Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 66 336-42. doi: 10.1001/archneurol.2008.582
33. M.A. Beydoun, A. Lhotsky, Y. Wang, G. Dal Forno, Y. An, E.J. Metter, L. Ferrucci, R. O'Brien, and A.B. Zonderman (2008) Association of adiposity status and changes in early to mid-adulthood with incidence of Alzheimer's disease. Am J Epidemiol 168 1179-89. doi: 10.1093/aje/kwn229
34. W.L. Xu, A.R. Atti, M. Gatz, N.L. Pedersen, B. Johansson, and L. Fratiglioni (2011) Midlife overweight and obesity increase late-life dementia risk: a population-based twin study. Neurology 76 1568-74. doi: 10.1212/WNL.0b013e3182190d09
35. M. Kivipelto, T. Ngandu, L. Fratiglioni, M. Viitanen, I. Kareholt, B. Winblad, E.L. Helkala, J. Tuomilehto, H. Soininen, and A. Nissinen (2005) Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 62 1556-60. doi: 10.1001/archneur.62.10.1556
36. N. Qizilbash, J. Gregson, M.E. Johnson, N. Pearce, I. Douglas, K. Wing, S.J. Evans, and S.J. Pocock (2015) BMI and risk of dementia in two million people over two decades: a retrospective cohort study. Lancet Diabetes Endocrinol. doi: 10.1016/S2213-8587(15)00033-9
37. R.A. Whitmer, D.R. Gustafson, E. Barrett-Connor, M.N. Haan, E.P. Gunderson, and K. Yaffe (2008) Central obesity and increased risk of dementia more than three decades later. Neurology 71 1057-64. doi: 10.1212/01.wnl.0000306313.89165.ef
38. J.A. Luchsinger, D. Cheng, M.X. Tang, N. Schupf, and R. Mayeux (2012) Central obesity in the elderly is related to late-onset Alzheimer disease. Alzheimer Dis Assoc Disord 26 101-5. doi: 10.1097/WAD.0b013e318222f0d4
39. D.R. Gustafson, K. Backman, M. Waern, S. Ostling, X. Guo, P. Zandi, M.M. Mielke, C. Bengtsson, and I. Skoog (2009) Adiposity indicators and dementia over 32 years in Sweden. Neurology 73 1559-66. doi: 10.1212/WNL.0b013e3181c0d4b6
40. J. Dallongeville, D.L. Bhatt, P.H. Steg, P. Ravaud, P.W. Wilson, K.A. Eagle, S. Goto, J.L. Mas, G. Montalescot, and R.R. Investigators (2012) Relation between body mass index, waist circumference, and cardiovascular outcomes in 19,579 diabetic patients with established vascular disease: the REACH Registry. Eur J Prev Cardiol 19 241-9. doi: 10.1177/1741826710394305
41. S. Yusuf, S. Hawken, S. Ounpuu, L. Bautista, M.G. Franzosi, P. Commerford, C.C. Lang, Z. Rumboldt, C.L. Onen, L. Lisheng, S. Tanomsup, P. Wangai, Jr., F. Razak, A.M. Sharma, S.S. Anand, and I.S. Investigators (2005) Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366 1640-9. doi: 10.1016/S0140-6736(05)67663-5
42. B. Herculano, M. Tamura, A. Ohba, M. Shimatani, N. Kutsuna, and T. Hisatsune (2013) beta-alanyl-L-histidine rescues cognitive deficits caused by feeding a high fat diet in a transgenic mouse model of Alzheimer's disease. J Alzheimers Dis 33 983-97. doi: 10.3233/JAD-2012-121324
43. C. Julien, C. Tremblay, A. Phivilay, L. Berthiaume, V. Emond, P. Julien, and F. Calon (2010) High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model. Neurobiol Aging 31 1516-31. doi: 10.1016/j.neurobiolaging.2008.08.022
44. M. Takalo, A. Haapasalo, H. Martiskainen, K.M. Kurkinen, H. Koivisto, P. Miettinen, V.K. Khandelwal, S. Kemppainen, D. Kaminska, P. Makinen, V. Leinonen, J. Pihlajamaki, H. Soininen, M. Laakso, H. Tanila, and M. Hiltunen (2014) High-fat diet increases tau expression in the brain of T2DM and AD mice independently of peripheral metabolic status. J Nutr Biochem 25 634-41. doi: 10.1016/j.jnutbio.2014.02.003
45. M.E. Orr, A. Salinas, R. Buffenstein, and S. Oddo (2014) Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology. Neurobiol Aging 35 1233-42. doi: 10.1016/j.neurobiolaging.2013.12.006
46. A.M. Barron, E.R. Rosario, R. Elteriefi, and C.J. Pike (2013) Sex-specific effects of high fat diet on indices of metabolic syndrome in 3xTg-AD mice: implications for Alzheimer's disease. PLoS One 8 e78554. doi: 10.1371/journal.pone.0078554
47. A.C. Granholm, H.A. Bimonte-Nelson, A.B. Moore, M.E. Nelson, L.R. Freeman, and K. Sambamurti (2008) Effects of a saturated fat and high cholesterol diet on memory and hippocampal morphology in the middle-aged rat. J Alzheimers Dis 14 133-45.
48. S.A. Farr, K.A. Yamada, D.A. Butterfield, H.M. Abdul, L. Xu, N.E. Miller, W.A. Banks, and J.E. Morley (2008) Obesity and hypertriglyceridemia produce cognitive impairment. Endocrinology 149 2628-36. doi: 10.1210/en.2007-1722
49. R. Molteni, R.J. Barnard, Z. Ying, C.K. Roberts, and F. Gomez-Pinilla (2002) A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience 112 803-14.
50. L.L. Hwang, C.H. Wang, T.L. Li, S.D. Chang, L.C. Lin, C.P. Chen, C.T. Chen, K.C. Liang, I.K. Ho, W.S. Yang, and L.C. Chiou (2010) Sex differences in high-fat diet-induced obesity, metabolic alterations and learning, and synaptic plasticity deficits in mice. Obesity (Silver Spring) 18 463-9. doi: 10.1038/oby.2009.273
51. A.J. Murray, N.S. Knight, L.E. Cochlin, S. McAleese, R.M. Deacon, J.N. Rawlins, and K. Clarke (2009) Deterioration of physical performance and cognitive function in rats with short-term high-fat feeding. FASEB J 23 4353-60. doi: 10.1096/fj.09-139691
52. D. Cao, H. Lu, T.L. Lewis, and L. Li (2007) Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. J Biol Chem 282 36275-82. doi: 10.1074/jbc.M703561200
53. T.M. Hsu, V.R. Konanur, L. Taing, R. Usui, B.D. Kayser, M.I. Goran, and S.E. Kanoski (2015) Effects of sucrose and high fructose corn syrup consumption on spatial memory function and hippocampal neuroinflammation in adolescent rats. Hippocampus 25 227-39. doi: 10.1002/hipo.22368
54. A. Jayaraman, D. Lent-Schochet, and C.J. Pike (2014) Diet-induced obesity and low testosterone increase neuroinflammation and impair neural function. J Neuroinflammation 11 162. doi: 10.1186/s12974-014-0162-y
55. E. Blazquez, E. Velazquez, V. Hurtado-Carneiro, and J.M. Ruiz-Albusac (2014) Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease. Front Endocrinol 5 161. doi: 10.3389/fendo.2014.00161
56. S.M. de la Monte, and M. Tong (2014) Brain metabolic dysfunction at the core of Alzheimer's disease. Biochem Pharmacol 88 548-59. doi: 10.1016/j.bcp.2013.12.012
57. L. Mosconi (2005) Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 32 486-510. doi: 10.1007/s00259-005-1762-7
58. S. Craft (2007) Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res 4 147-52.
59. K. Anthony, L.J. Reed, J.T. Dunn, E. Bingham, D. Hopkins, P.K. Marsden, and S.A. Amiel (2006) Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance: the cerebral basis for impaired control of food intake in metabolic syndrome? Diabetes 55 2986-92. doi: 10.2337/db06-0376
60. M.A. Reger, G.S. Watson, P.S. Green, C.W. Wilkinson, L.D. Baker, B. Cholerton, M.A. Fishel, S.R. Plymate, J.C. Breitner, W. DeGroodt, P. Mehta, and S. Craft (2008) Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology 70 440-8. doi: 10.1212/01.WNL.0000265401.62434.36
61. A. Claxton, L.D. Baker, A. Hanson, E.H. Trittschuh, B. Cholerton, A. Morgan, M. Callaghan, M. Arbuckle, C. Behl, and S. Craft (2015) Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia. J Alzheimers Dis 44 897-906. doi: 10.3233/JAD-141791
62. J.P. Thaler, and M.W. Schwartz (2010) Minireview: Inflammation and obesity pathogenesis: the hypothalamus heats up. Endocrinology 151 4109-15. doi: 10.1210/en.2010-0336
63. J.P. Thaler, C.X. Yi, E.A. Schur, S.J. Guyenet, B.H. Hwang, M.O. Dietrich, X. Zhao, D.A. Sarruf, V. Izgur, K.R. Maravilla, H.T. Nguyen, J.D. Fischer, M.E. Matsen, B.E. Wisse, G.J. Morton, T.L. Horvath, D.G. Baskin, M.H. Tschop, and M.W. Schwartz (2012) Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest 122 153-62. doi: 10.1172/JCI59660
64. A. Aguilar-Valles, W. Inoue, C. Rummel, and G.N. Luheshi (2015) Obesity, adipokines and neuroinflammation. Neuropharmacology. doi: 10.1016/j.neuropharm.2014.12.023
65. M. Verri, O. Pastoris, M. Dossena, R. Aquilani, F. Guerriero, G. Cuzzoni, L. Venturini, G. Ricevuti, and A.I. Bongiorno (2012) Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease. Int J Immunopathol Pharmacol 25 345-53.
66. H. Johnston, H. Boutin, and S.M. Allan (2011) Assessing the contribution of inflammation in models of Alzheimer's disease. Biochem Soc Trans 39 886-90. doi: 10.1042/BST0390886
67. Z. Tucsek, P. Toth, D. Sosnowska, T. Gautam, M. Mitschelen, A. Koller, G. Szalai, W.E. Sonntag, Z. Ungvari, and A. Csiszar (2014) Obesity in aging exacerbates blood-brain barrier disruption, neuroinflammation, and oxidative stress in the mouse hippocampus: effects on expression of genes involved in beta-amyloid generation and Alzheimer's disease. J Gerontol A Biol Sci Med Sci 69 1212-26. doi: 10.1093/gerona/glt177
68. D. Yu, B. Corbett, Y. Yan, G.X. Zhang, P. Reinhart, S.J. Cho, and J. Chin (2012) Early cerebrovascular inflammation in a transgenic mouse model of Alzheimer's disease. Neurobiol Aging 33 2942-7. doi: 10.1016/j.neurobiolaging.2012.02.023
69. S. Takeda, N. Sato, K. Ikimura, H. Nishino, H. Rakugi, and R. Morishita (2013) Increased blood-brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model. Neurobiol Aging 34 2064-70. doi: 10.1016/j.neurobiolaging.2013.02.010
70. S. Takeda, N. Sato, K. Uchio-Yamada, K. Sawada, T. Kunieda, D. Takeuchi, H. Kurinami, M. Shinohara, H. Rakugi, and R. Morishita (2010) Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proc Natl Acad Sci U S A 107 7036-41. doi: 10.1073/pnas.1000645107
71. S. Mandrekar-Colucci, and G.E. Landreth (2010) Microglia and inflammation in Alzheimer's disease. CNS Neurol Disord Drug Targets 9 156-67.
72. L. Bertram, C. Lange, K. Mullin, M. Parkinson, M. Hsiao, M.F. Hogan, B.M. Schjeide, B. Hooli, J. Divito, I. Ionita, H. Jiang, N. Laird, T. Moscarillo, K.L. Ohlsen, K. Elliott, X. Wang, D. Hu-Lince, M. Ryder, A. Murphy, S.L. Wagner, D. Blacker, K.D. Becker, and R.E. Tanzi (2008) Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am J Hum Genet 83 623-32. doi: 10.1016/j.ajhg.2008.10.008
73. A.C. Naj, G. Jun, G.W. Beecham, L.S. Wang, B.N. Vardarajan, J. Buros, P.J. Gallins, J.D. Buxbaum, G.P. Jarvik, P.K. Crane, E.B. Larson, T.D. Bird, B.F. Boeve, N.R. Graff-Radford, P.L. De Jager, D. Evans, J.A. Schneider, M.M. Carrasquillo, N. Ertekin-Taner, S.G. Younkin, C. Cruchaga, J.S. Kauwe, P. Nowotny, P. Kramer, J. Hardy, M.J. Huentelman, A.J. Myers, M.M. Barmada, F.Y. Demirci, C.T. Baldwin, R.C. Green, E. Rogaeva, P. St George-Hyslop, S.E. Arnold, R. Barber, T. Beach, E.H. Bigio, J.D. Bowen, A. Boxer, J.R. Burke, N.J. Cairns, C.S. Carlson, R.M. Carney, S.L. Carroll, H.C. Chui, D.G. Clark, J. Corneveaux, C.W. Cotman, J.L. Cummings, C. DeCarli, S.T. DeKosky, R. Diaz-Arrastia, M. Dick, D.W. Dickson, W.G. Ellis, K.M. Faber, K.B. Fallon, M.R. Farlow, S. Ferris, M.P. Frosch, D.R. Galasko, M. Ganguli, M. Gearing, D.H. Geschwind, B. Ghetti, J.R. Gilbert, S. Gilman, B. Giordani, J.D. Glass, J.H. Growdon, R.L. Hamilton, L.E. Harrell, E. Head, L.S. Honig, C.M. Hulette, B.T. Hyman, G.A. Jicha, L.W. Jin, N. Johnson, J. Karlawish, A. Karydas, J.A. Kaye, R. Kim, E.H. Koo, N.W. Kowall, J.J. Lah, A.I. Levey, A.P. Lieberman, O.L. Lopez, W.J. Mack, D.C. Marson, F. Martiniuk, D.C. Mash, E. Masliah, W.C. McCormick, S.M. McCurry, A.N. McDavid, A.C. McKee, M. Mesulam, B.L. Miller, et al. (2011) Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 43 436-41. doi: 10.1038/ng.801
74. P. Hollingworth, D. Harold, R. Sims, A. Gerrish, J.C. Lambert, M.M. Carrasquillo, R. Abraham, M.L. Hamshere, J.S. Pahwa, V. Moskvina, K. Dowzell, N. Jones, A. Stretton, C. Thomas, A. Richards, D. Ivanov, C. Widdowson, J. Chapman, S. Lovestone, J. Powell, P. Proitsi, M.K. Lupton, C. Brayne, D.C. Rubinsztein, M. Gill, B. Lawlor, A. Lynch, K.S. Brown, P.A. Passmore, D. Craig, B. McGuinness, S. Todd, C. Holmes, D. Mann, A.D. Smith, H. Beaumont, D. Warden, G. Wilcock, S. Love, P.G. Kehoe, N.M. Hooper, E.R. Vardy, J. Hardy, S. Mead, N.C. Fox, M. Rossor, J. Collinge, W. Maier, F. Jessen, E. Ruther, B. Schurmann, R. Heun, H. Kolsch, H. van den Bussche, I. Heuser, J. Kornhuber, J. Wiltfang, M. Dichgans, L. Frolich, H. Hampel, J. Gallacher, M. Hull, D. Rujescu, I. Giegling, A.M. Goate, J.S. Kauwe, C. Cruchaga, P. Nowotny, J.C. Morris, K. Mayo, K. Sleegers, K. Bettens, S. Engelborghs, P.P. De Deyn, C. Van Broeckhoven, G. Livingston, N.J. Bass, H. Gurling, A. McQuillin, R. Gwilliam, P. Deloukas, A. Al-Chalabi, C.E. Shaw, M. Tsolaki, A.B. Singleton, R. Guerreiro, T.W. Muhleisen, M.M. Nothen, S. Moebus, K.H. Jockel, N. Klopp, H.E. Wichmann, V.S. Pankratz, S.B. Sando, J.O. Aasly, M. Barcikowska, Z.K. Wszolek, D.W. Dickson, N.R. Graff-Radford, R.C. Petersen, et al. (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 43 429-35. doi: 10.1038/ng.803
75. O. Leavy (2015) Neuroimmunology: TREM2 in Alzheimer disease. Nat Rev Immunol 15 201. doi: 10.1038/nri3842
76. J.C. Lambert, S. Heath, G. Even, D. Campion, K. Sleegers, M. Hiltunen, O. Combarros, D. Zelenika, M.J. Bullido, B. Tavernier, L. Letenneur, K. Bettens, C. Berr, F. Pasquier, N. Fievet, P. Barberger-Gateau, S. Engelborghs, P. De Deyn, I. Mateo, A. Franck, S. Helisalmi, E. Porcellini, O. Hanon, I. European Alzheimer's Disease Initiative, M.M. de Pancorbo, C. Lendon, C. Dufouil, C. Jaillard, T. Leveillard, V. Alvarez, P. Bosco, M. Mancuso, F. Panza, B. Nacmias, P. Bossu, P. Piccardi, G. Annoni, D. Seripa, D. Galimberti, D. Hannequin, F. Licastro, H. Soininen, K. Ritchie, H. Blanche, J.F. Dartigues, C. Tzourio, I. Gut, C. Van Broeckhoven, A. Alperovitch, M. Lathrop, and P. Amouyel (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41 1094-9. doi: 10.1038/ng.439
77. D. Harold, R. Abraham, P. Hollingworth, R. Sims, A. Gerrish, M.L. Hamshere, J.S. Pahwa, V. Moskvina, K. Dowzell, A. Williams, N. Jones, C. Thomas, A. Stretton, A.R. Morgan, S. Lovestone, J. Powell, P. Proitsi, M.K. Lupton, C. Brayne, D.C. Rubinsztein, M. Gill, B. Lawlor, A. Lynch, K. Morgan, K.S. Brown, P.A. Passmore, D. Craig, B. McGuinness, S. Todd, C. Holmes, D. Mann, A.D. Smith, S. Love, P.G. Kehoe, J. Hardy, S. Mead, N. Fox, M. Rossor, J. Collinge, W. Maier, F. Jessen, B. Schurmann, R. Heun, H. van den Bussche, I. Heuser, J. Kornhuber, J. Wiltfang, M. Dichgans, L. Frolich, H. Hampel, M. Hull, D. Rujescu, A.M. Goate, J.S. Kauwe, C. Cruchaga, P. Nowotny, J.C. Morris, K. Mayo, K. Sleegers, K. Bettens, S. Engelborghs, P.P. De Deyn, C. Van Broeckhoven, G. Livingston, N.J. Bass, H. Gurling, A. McQuillin, R. Gwilliam, P. Deloukas, A. Al-Chalabi, C.E. Shaw, M. Tsolaki, A.B. Singleton, R. Guerreiro, T.W. Muhleisen, M.M. Nothen, S. Moebus, K.H. Jockel, N. Klopp, H.E. Wichmann, M.M. Carrasquillo, V.S. Pankratz, S.G. Younkin, P.A. Holmans, M. O'Donovan, M.J. Owen, and J. Williams (2009) Genome wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41 1088-93. doi: 10.1038/ng.440
78. Z. Chen, and B.D. Trapp (2015) Microglia and neuroprotection. J Neurochem. doi: 10.1111/jnc.13062
79. C.N. Parkhurst, G. Yang, I. Ninan, J.N. Savas, J.R. Yates, 3rd, J.J. Lafaille, B.L. Hempstead, D.R. Littman, and W.B. Gan (2013) Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 155 1596-609. doi: 10.1016/j.cell.2013.11.030
80. H.S. Suh, M.L. Zhao, L. Derico, N. Choi, and S.C. Lee (2013) Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators. J Neuroinflammation 10 37. doi: 10.1186/1742-2094-10-37
81. C.A. Colton (2009) Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 4 399-418. doi: 10.1007/s11481-009-9164-4
82. J.L. Teeling, and V.H. Perry (2009) Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: underlying mechanisms. Neuroscience 158 1062-73. doi: 10.1016/j.neuroscience.2008.07.031
83. M. Meyer-Luehmann, T.L. Spires-Jones, C. Prada, M. Garcia-Alloza, A. de Calignon, A. Rozkalne, J. Koenigsknecht-Talboo, D.M. Holtzman, B.J. Bacskai, and B.T. Hyman (2008) Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 451 720-4. doi: 10.1038/nature06616
84. E. Karran, M. Mercken, and B. De Strooper (2011) The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10 698-712. doi: 10.1038/nrd3505
85. J. Koenigsknecht-Talboo, and G.E. Landreth (2005) Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J Neurosci 25 8240-9. doi: 10.1523/JNEUROSCI.1808-05.2005
86. S. Jimenez, D. Baglietto-Vargas, C. Caballero, I. Moreno-Gonzalez, M. Torres, R. Sanchez-Varo, D. Ruano, M. Vizuete, A. Gutierrez, and J. Vitorica (2008) Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: age dependent switch in the microglial phenotype from alternative to classic. J Neurosci 28 11650-61. doi: 10.1523/JNEUROSCI.3024-08.2008
87. G.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 87-91.
88. G.S. Hotamisligil (2006) Inflammation and metabolic disorders. Nature 444 860-7. doi: 10.1038/nature05485
89. A.H. Kissebah, N. Vydelingum, R. Murray, D.J. Evans, A.J. Hartz, R.K. Kalkhoff, and P.W. Adams (1982) Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54 254-60. doi: 10.1210/jcem-54-2-254
90. D.J. Nieves, M. Cnop, B. Retzlaff, C.E. Walden, J.D. Brunzell, R.H . Knopp, and S.E. Kahn (2003) The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 52 172-9.
91. D. Patsouris, P.P. Li, D. Thapar, J. Chapman, J.M. Olefsky, and J.G. Neels (2008) Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 8 301-9. doi: 10.1016/j.cmet.2008.08.015
92. J.P. Thaler, S.J. Guyenet, M.D. Dorfman, B.E. Wisse, and M.W. Schwartz (2013) Hypothalamic inflammation: marker or mechanism of obesity pathogenesis? Diabetes 62 2629-34. doi: 10.2337/db12-1605
93. C.T. De Souza, E.P. Araujo, S. Bordin, R. Ashimine, R.L. Zollner, A.C. Boschero, M.J. Saad, and L.A. Velloso (2005) Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146 4192-9. doi: 10.1210/en.2004-1520
94. M. Milanski, G. Degasperi, A. Coope, J. Morari, R. Denis, D.E. Cintra, D.M. Tsukumo, G. Anhe, M.E. Amaral, H.K. Takahashi, R. Curi, H.C. Oliveira, J.B. Carvalheira, S. Bordin, M.J. Saad, and L.A. Velloso (2009) Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci 29 359-70. doi: 10.1523/JNEUROSCI.2760-08.2009
95. B. Vandanmagsar, Y.H. Youm, A. Ravussin, J.E. Galgani, K. Stadler, R.L. Mynatt, E. Ravussin, J.M. Stephens, and V.D. Dixit (2011) The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 17 179-88. doi: 10.1038/nm.2279
96. R.V. Considine, M.K. Sinha, M.L. Heiman, A. Kriauciunas, T.W. Stephens, M.R. Nyce, J.P. Ohannesian, C.C. Marco, L.J. McKee, T.L. Bauer, and et al. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334 292-5. doi: 10.1056/NEJM199602013340503
97. H.K. Park, and R.S. Ahima (2015) Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism 64 24-34. doi: 10.1016/j.metabol.2014.08.004
98. J. Conde, M. Scotece, V. Abella, V. Lopez, J. Pino, J.J. Gomez-Reino, and O. Gualillo (2014) An update on leptin as immunomodulator. Expert Rev Clin Immunol 10 1165-70. doi: 10.1586/1744666X.2014.942289
99. G.M. Lord, G. Matarese, J.K. Howard, R.J. Baker, S.R. Bloom, and R.I. Lechler (1998) Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394 897-901. doi: 10.1038/29795
100. C. Martin-Romero, J. Santos-Alvarez, R. Goberna, and V. Sanchez-Margalet (2000) Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol 199 15-24. doi: 10.1006/cimm.1999.1594
101. J. Santos-Alvarez, R. Goberna, and V. Sanchez-Margalet (1999) Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 194 6-11. doi: 10.1006/cimm.1999.1490
102. G.M. Raso, M. Pacilio, E. Esposito, A. Coppola, R. Di Carlo, and R. Meli (2002) Leptin potentiates IFN-gamma-induced expression of nitric oxide synthase and cyclo947 oxygenase-2 in murine macrophage J774A.1. Br J Pharmacol 137 799-804. doi: 10.1038/sj.bjp.0704903
103. E.D. Carlton, G.E. Demas, and S.S. French (2012) Leptin, a neuroendocrine mediator of immune responses, inflammation, and sickness behaviors. Horm Behav 62 272-9. doi: 10.1016/j.yhbeh.2012.04.010
104. J.M. Johnston, W.T. Hu, D.W. Fardo, S.J. Greco, G. Perry, T.J. Montine, J.Q. Trojanowski, L.M. Shaw, J.W. Ashford, N. Tezapsidis, and I. Alzheimer's Disease Neuroimaging (2014) Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential. Curr Alzheimer Res 11 165-74.
105. S. Maioli, M. Lodeiro, P. Merino-Serrais, F. Falahati, W. Khan, E. Puerta, A. Codita, R. Rimondini, M.J. Ramirez, A. Simmons, F. Gil-Bea, E. Westman, A. Cedazo-Minguez, and I. Alzheimer's Disease Neuroimaging (2015) Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer's disease. Aging Cell 14 122-9. doi: 10.1111/acel.12281
106. W. Lieb, A.S. Beiser, R.S. Vasan, Z.S. Tan, R. Au, T.B. Harris, R. Roubenoff, S. Auerbach, C. DeCarli, P.A. Wolf, and S. Seshadri (2009) Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA 302 2565-72. doi: 10.1001/jama.2009.1836
107. D.C. Fewlass, K. Noboa, F.X. Pi-Sunyer, J.M. Johnston, S.D. Yan, and N. Tezapsidis (2004) Obesity-related leptin regulates Alzheimer's Abeta. FASEB J 18 1870-8. doi: 10.1096/fj.04-2572com
108. S.J. Greco, S. Sarkar, J.M. Johnston, X. Zhu, B. Su, G. Casadesus, J.W. Ashford, M.A. Smith, and N. Tezapsidis (2008) Leptin reduces Alzheimer's disease-related tau phosphorylation in neuronal cells. Biochem Biophys Res Commun 376 536-41. doi: 10.1016/j.bbrc.2008.09.026
109. D.J. Bonda, J.G. Stone, S.L. Torres, S.L. Siedlak, G. Perry, R. Kryscio, G. Jicha, G. Casadesus, M.A. Smith, X. Zhu, and H.G. Lee (2014) Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance. J Neurochem 128 162-72. doi: 10.1111/jnc.12380
110. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante, Jr. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112 1796-808. doi: 10.1172/JCI19246
111. G.S. Hotamisligil, P. Arner, J.F. Caro, R.L. Atkinson, and B.M. Spiegelman (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95 2409-15. doi: 10.1172/JCI117936
112. C. Tsigos, I. Kyrou, E. Chala, P. Tsapogas, J.C. Stavridis, S.A. Raptis, and N. Katsilambros (1999) Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism 48 1332-5.
113. G. Flynn, S. Maru, J. Loughlin, I.A. Romero, and D. Male (2003) Regulation of chemokine receptor expression in human microglia and astrocytes. J Neuroimmunol 136 84-93.
114. M.S. Beattie, G.E. Hermann, R.C. Rogers, and J.C. Bresnahan (2002) Cell death in models of spinal cord injury. Prog Brain Res 137 37-47.
115. A.R. Ferguson, R.N. Christensen, J.C. Gensel, B.A. Miller, F. Sun, E.C. Beattie, J.C. Bresnahan, and M.S. Beattie (2008) Cell death after spinal cord injury is exacerbated by rapid TNF alpha-induced trafficking of GluR2-lacking AMPARs to the plasma membrane. J Neurosci 28 11391-400. doi: 10.1523/JNEUROSCI.3708-08.2008
116. M. Yamamoto, T. Kiyota, M. Horiba, J.L. Buescher, S.M. Walsh, H.E. Gendelman, and T. Ikezu (2007) Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. Am J Pathol 170 680-92. doi: 10.2353/ajpath.2007.060378
117. S. Lopez, B. Bermudez, Y.M. Pacheco, J. Villar, R. Abia, and F.J. Muriana (2008) Distinctive postprandial modulation of beta cell function and insulin sensitivity by dietary fats: monounsaturated compared with saturated fatty acids. Am J Clin Nutr 88 638-44.
118. K.T. Akama, and L.J. Van Eldik (2000) Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB inducing kinase-dependent signaling mechanism. J Biol Chem 275 7918-24.
119. L. Meda, M.A. Cassatella, G.I. Szendrei, L. Otvos, Jr., P. Baron, M. Villalba, D. Ferrari, and F. Rossi (1995) Activation of microglial cells by beta-amyloid protein and interferon1007 gamma. Nature 374 647-50. doi: 10.1038/374647a0
120. X. Cheng, L. Yang, P. He, R. Li, and Y. Shen (2010) Differential activation of tumor necrosis factor receptors distinguishes between brains from Alzheimer's disease and non-demented patients. J Alzheimers Dis 19 621-30. doi: 10.3233/JAD-2010-1253
121. R. Li, R. Strohmeyer, Z. Liang, L.F. Lue, and J. Rogers (2004) CCAAT/enhancer binding protein delta (C/EBPdelta) expression and elevation in Alzheimer's disease. Neurobiol Aging 25 991-9. doi: 10.1016/j.neurobiolaging.2003.10.016
122. Z. Xie, M. Wei, T.E. Morgan, P. Fabrizio, D. Han, C.E. Finch, and V.D. Longo (2002) Peroxynitrite mediates neurotoxicity of amyloid beta-peptide1-42- and lipopolysaccharide-activated microglia. J Neurosci 22 3484-92. doi: 20026340
123. P. He, Z. Zhong, K. Lindholm, L. Berning, W. Lee, C. Lemere, M. Staufenbiel, R. Li, and Y. Shen (2007) Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice. J Cell Biol 178 829-41. doi: 10.1083/jcb.200705042
124. J.P. Bastard, C. Jardel, E. Bruckert, P. Blondy, J. Capeau, M. Laville, H. Vidal, and B. Hainque (2000) Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85 3338-42. doi: 10.1210/jcem.85.9.6839
125. P.A. Kern, S. Ranganathan, C. Li, L. Wood, and G. Ranganathan (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280 E745-51.
126. A.D. Pradhan, J.E. Manson, N. Rifai, J.E. Buring, and P.M. Ridker (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286 327-34.
127. J. Plutzky (2001) Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol 88 10K-15K.
128. L. Fontana, J.C. Eagon, M.E. Trujillo, P.E. Scherer, and S. Klein (2007) Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 56 1010-3. doi: 10.2337/db06-1656
129. V. Wallenius, K. Wallenius, B. Ahren, M. Rudling, H. Carlsten, S.L. Dickson, C. Ohlsson, and J.O. Jansson (2002) Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8 75-9. doi: 10.1038/nm0102-75
130. J.J. Senn, P.J. Klover, I.A. Nowak, and R.A. Mooney (2002) Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51 3391-9.
131. A. Singh-Manoux, A. Dugravot, E. Brunner, M. Kumari, M. Shipley, A. Elbaz, and M. Kivimaki (2014) Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife. Neurology 83 486-93. doi: 10.1212/WNL.0000000000000665
132. S.Y. Chen, T.F. Chen, L.C. Lai, J.H. Chen, Y. Sun, L.L. Wen, P.K. Yip, Y.M. Chu, and Y.C. Chen (2012) Sequence variants of interleukin 6 (IL-6) are significantly associated with a decreased risk of late-onset Alzheimer's disease. J Neuroinflammation 9 21. doi: 10.1186/1742-2094-9-21
133. A. Papassotiropoulos, M. Bagli, F. Jessen, T.A. Bayer, W. Maier, M.L. Rao, and R. Heun (1999) A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease. Ann Neurol 45 666-8.
134. A. Flex, S. Giovannini, F. Biscetti, R. Liperoti, G. Spalletta, G. Straface, F. Landi, F. Angelini, C. Caltagirone, G. Ghirlanda, and R. Bernabei (2014) Effect of proinflammatory gene polymorphisms on the risk of Alzheimer's disease. Neurodegener Dis 13 230-6. doi: 10.1159/000353395
135. J. Bauer, S. Strauss, U. Schreiter-Gasser, U. Ganter, P. Schlegel, I. Witt, B. Yolk, and M. Berger (1991) Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett 285 111-4.
136. D. Blum-Degen, T. Muller, W. Kuhn, M. Gerlach, H. Przuntek, and P. Riederer (1995) Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett 202 17-20.
137. M. Erta, A. Quintana, and J. Hidalgo (2012) Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci 8 1254-66. doi: 10.7150/ijbs.4679
138. R.A. Quintanilla, D.I. Orellana, C. Gonzalez-Billault, and R.B. Maccioni (2004) Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Exp Cell Res 295 245-57. doi: 10.1016/j.yexcr.2004.01.002
139. S.E. Hankinson, G.A. Colditz, D.J. Hunter, J.E. Manson, W.C. Willett, M.J. Stampfer, C. Longcope, and F.E. Speizer (1995) Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses' Health Study (United States). Cancer Causes Control 6 217-24.
140. L. Bernstein, M.C. Pike, R.K. Ross, H.L. Judd, J.B. Brown, and B.E. Henderson (1985) Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst 74 741-5.
141. U. Ptok, K. Barkow, and R. Heun (2002) Fertility and number of children in patients with Alzheimer's disease. Arch Womens Ment Health 5 83-6. doi: 10.1007/s00737-002-0142-6
142. M.S. Beeri, M. Rapp, J. Schmeidler, A. Reichenberg, D.P. Purohit, D.P. Perl, H.T. Grossman, I. Prohovnik, V. Haroutunian, and J.M. Silverman (2009) Number of children is associated with neuropathology of Alzheimer's disease in women. Neurobiol Aging 30 1184-91. doi: 10.1016/j.neurobiolaging.2007.11.011
143. M. Colucci, S. Cammarata, A. Assini, R. Croce, F. Clerici, C. Novello, L. Mazzella, N. Dagnino, C. Mariani, and P. Tanganelli (2006) The number of pregnancies is a risk factor for Alzheimer's disease. Eur J Neurol 13 1374-7. doi: 10.1111/j.1468-1331.2006.01520.x
144. R.N. McLay, P.M. Maki, and C.G. Lyketsos (2003) Nulliparity and late menopause are associated with decreased cognitive decline. J Neuropsychiatry Clin Neurosci 15 161-7.
145. R. Bove, E. Secor, L.B. Chibnik, L.L. Barnes, J.A. Schneider, D.A. Bennett, and P.L. De Jager (2014) Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology 82 222-9. doi: 10.1212/WNL.0000000000000033
146. W.A. Rocca, J.H. Bower, D.M. Maraganore, J.E. Ahlskog, B.R. Grossardt, M. de Andrade, and L.J. Melton, 3rd (2007) Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 69 1074-83. doi: 10.1212/01.wnl.0000276984.19542.e6
147. W.A. Rocca, B.R. Grossardt, and L.T. Shuster (2011) Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res 1379 188-98. doi: 10.1016/j.brainres.2010.10.031
148. T.K. Phung, B.L. Waltoft, T.M. Laursen, A. Settnes, L.V. Kessing, P.B. Mortensen, and G. Waldemar (2010) Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study. Dement Geriatr Cogn Disord 30 43-50. doi: 10.1159/000314681
149. B. Imtiaz, M. Tuppurainen, M. Tiihonen, M. Kivipelto, H. Soininen, S. Hartikainen, and A.M. Tolppanen (2014) Oophorectomy, hysterectomy, and risk of Alzheimer's disease: a nationwide case-control study. J Alzheimers Dis 42 575-81. doi: 10.3233/JAD-140336
150. E.R. Rosario, L. Chang, E.H. Head, F.Z. Stanczyk, and C.J. Pike (2011) Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease. Neurobiol Aging 32 604-13. doi: 10.1016/j.neurobiolaging.2009.04.008
151. X. Yue, M. Lu, T. Lancaster, P. Cao, S. Honda, M. Staufenbiel, N. Harada, Z. Zhong, Y. Shen, and R. Li (2005) Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. Proc Natl Acad Sci U S A 102 19198-203. doi: 10.1073/pnas.0505203102
152. J.J. Manly, C.A. Merchant, D.M. Jacobs, S.A. Small, K. Bell, M. Ferin, and R. Mayeux (2000) Endogenous estrogen levels and Alzheimer's disease among postmenopausal women. Neurology 54 833-7.
153. V.W. Henderson, A. Paganini-Hill, C.K. Emanuel, M.E. Dunn, and J.G. Buckwalter (1994) Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol 51 896-900.
154. V.W. Henderson, L. Watt, and J.G. Buckwalter (1996) Cognitive skills associated with estrogen replacement in women with Alzheimer's disease. Psychoneuroendocrinology 21 421-30.
155. P.P. Zandi, M.C. Carlson, B.L. Plassman, K.A. Welsh-Bohmer, L.S. Mayer, D.C. Steffens, J.C. Breitner, and I. Cache County Memory Study (2002) Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288 2123-9.
156. C. Kawas, S. Resnick, A. Morrison, R. Brookmeyer, M. Corrada, A. Zonderman, C. Bacal, D.D. Lingle, and E. Metter (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 48 1517-21.
157. M.X. Tang, D. Jacobs, Y. Stern, K. Marder, P. Schofield, B. Gurland, H. Andrews, and R. Mayeux (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348 429-32. doi: 10.1016/S0140-6736(96)03356-9
158. J.C. Carroll, E.R. Rosario, L. Chang, F.Z. Stanczyk, S. Oddo, F.M. LaFerla, and C.J. Pike (2007) Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci 27 13357-65. doi: 10.1523/JNEUROSCI.2718-07.2007
159. H. Zheng, H. Xu, S.N. Uljon, R. Gross, K. Hardy, J. Gaynor, J. Lafrancois, J. Simpkins, L.M. Refolo, S. Petanceska, R. Wang, and K. Duff (2002) Modulation of A(beta) peptides by estrogen in mouse models. J Neurochem 80 191-6.
160. L. Zhao, J. Yao, Z. Mao, S. Chen, Y. Wang, and R.D. Brinton (2011) 17beta-Estradiol regulates insulin-degrading enzyme expression via an ERbeta/PI3-K pathway in hippocampus: relevance to Alzheimer's prevention. Neurobiol Aging 32 1949-63. doi: 10.1016/j.neurobiolaging.2009.12.010
161. S.A. Shumaker, C. Legault, S.R. Rapp, L. Thal, R.B. Wallace, J.K. Ockene, S.L. Hendrix, B.N. Jones, 3rd, A.R. Assaf, R.D. Jackson, J.M. Kotchen, S. Wassertheil-Smoller, J. Wactawski-Wende, and W. Investigators (2003) Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289 2651-62. doi: 10.1001/jama.289.20.2651
162. S.A. Shumaker, C. Legault, L. Kuller, S.R. Rapp, L. Thal, D.S. Lane, H. Fillit, M.L. Stefanick, S.L. Hendrix, C.E. Lewis, K. Masaki, L.H. Coker, and S. Women's Health Initiative Memory (2004) Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291 2947-58. doi: 10.1001/jama.291.24.2947
163. P.M. Maki (2006) Potential importance of early initiation of hormone therapy for cognitive benefit. Menopause 13 6-7. doi: 10.1097/01.gme.0000194822.76774.30
164. Y.Z. Bagger, L.B. Tanko, P. Alexandersen, G. Qin, C. Christiansen, and P.S. Group (2005) Early postmenopausal hormone therapy may prevent cognitive impairment later in life. Menopause 12 12-7.
165. V.W. Henderson, K.S. Benke, R.C. Green, L.A. Cupples, L.A. Farrer, and M.S. Group (2005) Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiatry 76 103-5. doi: 10.1136/jnnp.2003.024927
166. R.A. Whitmer, C.P. Quesenberry, J. Zhou, and K. Yaffe (2011) Timing of hormone therapy and dementia: the critical window theory revisited. Ann Neurol 69 163-9. doi: 10.1002/ana.22239
167. H. Shao, J.C. Breitner, R.A. Whitmer, J. Wang, K. Hayden, H. Wengreen, C. Corcoran, J. Tschanz, M. Norton, R. Munger, K. Welsh-Bohmer, P.P. Zandi, and I. Cache County (2012) Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study. Neurology 79 1846-52. doi: 10.1212/WNL.0b013e318271f823
168. V. Leduc, D. Domenger, L. De Beaumont, D. Lalonde, S. Belanger-Jasmin, and J. Poirier (2011) Function and comorbidities of apolipoprotein e in Alzheimer's disease. Int J Alzheimers Dis 2011 974361. doi: 10.4061/2011/974361
169. J. Naslund, J. Thyberg, L.O. Tjernberg, C. Wernstedt, A.R. Karlstrom, N. Bogdanovic, S.E. Gandy, L. Lannfelt, L. Terenius, and C. Nordstedt (1995) Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain. Neuron 15 219-28.
170. C.M. Brown, E. Choi, Q. Xu, M.P. Vitek, and C.A. Colton (2008) The APOE4 genotype alters the response of microglia and macrophages to 17beta-estradiol. Neurobiol Aging 29 1783-94. doi: 10.1016/j.neurobiolaging.2007.04.018
171. K. Yaffe, M. Haan, A. Byers, C. Tangen, and L. Kuller (2000) Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology 54 1949-54.
172. L.A. Farrer, L.A. Cupples, J.L. Haines, B. Hyman, W.A. Kukull, R. Mayeux, R.H. Myers, M.A. Pericak-Vance, N. Risch, and C.M. van Duijn (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278 1349-56.
173. P.M. Bretsky, J.G. Buckwalter, T.E. Seeman, C.A. Miller, J. Poirier, G.D. Schellenberg, C.E. Finch, and V.W. Henderson (1999) Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. Alzheimer Dis Assoc Disord 13 216-21.
174. H. Payami, S. Zareparsi, K.R. Montee, G.J. Sexton, J.A. Kaye, T.D. Bird, C.E. Yu, E.M. Wijsman, L.L. Heston, M. Litt, and G.D. Schellenberg (1996) Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet 58 803-11.
175. R.P. Wildman, P.G. Tepper, S. Crawford, J.S. Finkelstein, K. Sutton-Tyrrell, R.C. Thurston, N. Santoro, B. Sternfeld, and G.A. Greendale (2012) Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from the Study of Women's Health Across the Nation. J Clin Endocrinol Metab 97 E1695-704. doi: 10.1210/jc.2012-1614
176. J.R. Guthrie, L. Dennerstein, and E.C. Dudley (1999) Weight gain and the menopause: a 5-year prospective study. Climacteric 2 205-11.
177. B. Sternfeld, H. Wang, C.P. Quesenberry, Jr., B. Abrams, S.A. Everson-Rose, G.A. Greendale, K.A. Matthews, J.I. Torrens, and M. Sowers (2004) Physical activity and changes in weight and waist circumference in midlife women: findings from the Study of Women's Health Across the Nation. Am J Epidemiol 160 912-22. doi: 10.1093/aje/kwh299
178. S.C. Ho, S. Wu, S.G. Chan, and A. Sham (2010) Menopausal transition and changes of body composition: a prospective study in Chinese perimenopausal women. Int J Obes (Lond) 34 1265-74. doi: 10.1038/ijo.2010.33
179. C. Bjorkelund, L. Lissner, S. Andersson, L. Lapidus, and C. Bengtsson (1996) Reproductive history in relation to relative weight and fat distribution. Int J Obes Relat Metab Disord 20 213-9.
180. E.T. Poehlman, M.J. Toth, and A.W. Gardner (1995) Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med 123 673-5.
181. D. Rachon, and H. Teede (2010) Ovarian function and obesity--interrelationship, impact on women's reproductive lifespan and treatment options. Mol Cell Endocrinol 316 172-9. doi: 10.1016/j.mce.2009.09.026
182. M.C. Carr (2003) The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88 2404-11. doi: 10.1210/jc.2003-030242
183. G.J. Cho, J.H. Lee, H.T. Park, J.H. Shin, S.C. Hong, T. Kim, J.Y. Hur, K.W. Lee, Y.K. Park, and S.H. Kim (2008) Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome. Menopause 15 524-9. doi: 10.1097/gme.0b013e3181559860
184. B.L. Wajchenberg (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21 697-738. doi: 10.1210/edrv.21.6.0415
185. I. Janssen, L.H. Powell, S. Crawford, B. Lasley, and K. Sutton-Tyrrell (2008) Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation. Arch Intern Med 168 1568-75. doi: 10.1001/archinte.168.14.1568
186. E. Barrett-Connor, H.G. Schrott, G. Greendale, D. Kritz-Silverstein, M.A. Espeland, M.P. Stern, T. Bush, and J.A. Perlman (1996) Factors associated with glucose and insulin levels in healthy postmenopausal women. Diabetes Care 19 333-40.
187. C.K. Sites, J. Calles-Escandon, M. Brochu, M. Butterfield, T. Ashikaga, and E.T. Poehlman (2000) Relation of regional fat distribution to insulin sensitivity in postmenopausal women. Fertil Steril 73 61-5.
188. A. Tchernof, J. Calles-Escandon, C.K. Sites, and E.T. Poehlman (1998) Menopause, central body fatness, and insulin resistance: effects of hormone-replacement therapy. Coron Artery Dis 9 503-11.
189. R.E. Stubbins, V.B. Holcomb, J. Hong, and N.P. Nunez (2012) Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance. Eur J Nutr 51 861-70. doi: 10.1007/s00394-011-0266-4
190. N.H. Rogers, J.W. Perfield, 2nd, K.J. Strissel, M.S. Obin, and A.S. Greenberg (2009) Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology 150 2161-8. doi: 10.1210/en.2008-1405
191. S.R. Salpeter, J.M. Walsh, T.M. Ormiston, E. Greyber, N.S. Buckley, and E.E. Salpeter (2006) Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab 8 538-54. doi: 10.1111/j.1463-1326.2005.00545.x
192. J. Haarbo, U. Marslew, A. Gotfredsen, and C. Christiansen (1991) Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 40 1323-6.
193. M. Ahtiainen, M. Alen, E. Pollanen, S. Pulkkinen, P.H. Ronkainen, U.M. Kujala, J. Kaprio, S. Sipila, and V. Kovanen (2012) Hormone therapy is associated with better body composition and adipokine/glucose profiles: a study with monozygotic co-twin control design. Menopause 19 1329-35. doi: 10.1097/gme.0b013e31825a3344
194. K. Kristensen, S.B. Pedersen, P. Vestergaard, L. Mosekilde, and B. Richelsen (1999) Hormone replacement therapy affects body composition and leptin differently in obese and non-obese postmenopausal women. J Endocrinol 163 55-62.
195. S.H. Golden, C. Kim, E. Barrett-Connor, B. Nan, S. Kong, R. Goldberg, and G. Diabetes Prevention Program Research (2013) The association of elective hormone therapy with changes in lipids among glucose intolerant postmenopausal women in the diabetes prevention program. Metabolism 62 1313-22. doi: 10.1016/j.metabol.2013.04.005
196. E.A. Ryan, and L. Enns (1988) Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab 67 341-7. doi: 10.1210/jcem-67-2-341
197. M.R. Meyer, D.J. Clegg, E.R. Prossnitz, and M. Barton (2011) Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol (Oxf) 203 259-69. doi: 10.1111/j.1748-1716.2010.02237.x
198. M.E. Jones, A.W. Thorburn, K.L. Britt, K.N. Hewitt, N.G. Wreford, J. Proietto, O.K. Oz, B.J. Leury, K.M. Robertson, S. Yao, and E.R. Simpson (2000) Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A 97 12735-40. doi: 10.1073/pnas.97.23.12735
199. P.A. Heine, J.A. Taylor, G.A. Iwamoto, D.B. Lubahn, and P.S. Cooke (2000) Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A 97 12729-34. doi: 10.1073/pnas.97.23.12729
200. G. Bryzgalova, H. Gao, B. Ahren, J.R. Zierath, D. Galuska, T.L. Steiler, K. Dahlman-Wright, S. Nilsson, J.A. Gustafsson, S. Efendic, and A. Khan (2006) Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 49 588-97. doi: 10.1007/s00125-005-0105-3
201. R. Yonezawa, T. Wada, N. Matsumoto, M. Morita, K. Sawakawa, Y. Ishii, M. Sasahara, H. Tsuneki, S. Saito, and T. Sasaoka (2012) Central versus peripheral impact of estradiol on the impaired glucose metabolism in ovariectomized mice on a high-fat diet. Am J Physiol Endocrinol Metab 303 E445-56. doi: 10.1152/ajpendo.00638.2011
202. J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz (2002) Changes in proinflammatory cytokine activity after menopause. Endocr Rev 23 90-119. doi: 10.1210/edrv.23.1.0456
203. R.H. Straub (2007) The complex role of estrogens in inflammation. Endocr Rev 28 521-74. doi: 10.1210/er.2007-0001
204. S.C. Gilliver (2010) Sex steroids as inflammatory regulators. J Steroid Biochem Mol Biol 120 105-15. doi: 10.1016/j.jsbmb.2009.12.015
205. G. Camilleri, M. Borg, S. Brincat, P. Schembri-Wismayer, M. Brincat, and J. Calleja-Agius (2012) The role of cytokines in cardiovascular disease in menopause. Climacteric 15 524-30. doi: 10.3109/13697137.2012.700743
206. A.A. Knowlton, and A.R. Lee (2012) Estrogen and the cardiovascular system. Pharmacol Ther 135 54-70. doi: 10.1016/j.pharmthera.2012.03.007
207. M. Martin-Millan, and S. Castaneda (2013) Estrogens, osteoarthritis and inflammation. Joint Bone Spine 80 368-73. doi: 10.1016/j.jbspin.2012.11.008
208. U. Islander, C. Jochems, M.K. Lagerquist, H. Forsblad-d'Elia, and H. Carlsten (2011) Estrogens in rheumatoid arthritis; the immune system and bone. Mol Cell Endocrinol 335 14-29. doi: 10.1016/j.mce.2010.05.018
209. N.C. Berchtold, D.H. Cribbs, P.D. Coleman, J. Rogers, E. Head, R. Kim, T. Beach, C. Miller, J. Troncoso, J.Q. Trojanowski, H.R. Zielke, and C.W. Cotman (2008) Gene expression changes in the course of normal brain aging are sexually dimorphic. Proc Natl Acad Sci U S A 105 15605-10. doi: 10.1073/pnas.0806883105
210. M. Sarvari, E. Hrabovszky, I. Kallo, N. Solymosi, I. Liko, N. Berchtold, C. Cotman, and Z. Liposits (2012) Menopause leads to elevated expression of macrophage-associated genes in the aging frontal cortex: rat and human studies identify strikingly similar changes. J Neuroinflammation 9 264. doi: 10.1186/1742-2094-9-264
211. M. Sarvari, E. Hrabovszky, I. Kallo, N. Solymosi, K. Toth, I. Liko, J. Szeles, S. Maho, B. Molnar, and Z. Liposits (2011) Estrogens regulate neuroinflammatory genes via estrogen receptors alpha and beta in the frontal cortex of middle-aged female rats. J Neuroinflammation 8 82. doi: 10.1186/1742-2094-8-82
212. V. Benedusi, C. Meda, S. Della Torre, G. Monteleone, E. Vegeto, and A. Maggi (2012) A lack of ovarian function increases neuroinflammation in aged mice. Endocrinology 153 2777-88. doi: 10.1210/en.2011-1925
213. D.K. Lewis, S. Bake, K. Thomas, M.K. Jezierski, and F. Sohrabji (2010) A high cholesterol diet elevates hippocampal cytokine expression in an age and estrogen-dependent manner in female rats. J Neuroimmunol 223 31-8. doi: 10.1016/j.jneuroim.2010.03.024
214. V.L. Nordell, M.M. Scarborough, A.K. Buchanan, and F. Sohrabji (2003) Differential effects of estrogen in the injured forebrain of young adult and reproductive senescent animals. Neurobiol Aging 24 733-43.
215. C.J. Pike, J.C. Carroll, E.R. Rosario, and A.M. Barron (2009) Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol 30 239-58. doi: 10.1016/j.yfrne.2009.04.015
216. F. Yin, J. Yao, H. Sancheti, T. Feng, R.C. Melcangi, T.E. Morgan, C.E. Finch, C.J. Pike, W.J. Mack, E. Cadenas, and R.D. Brinton (2015) The perimenopausal aging transition in the female rat brain: decline in bioenergetic systems and synaptic plasticity. Neurobiol Aging. doi: 10.1016/j.neurobiolaging.2015.03.013